Jeffrey Segal, Director at INVO Bioscience, Inc. (INVO), bought 9,211 shares at $0.95 ($9K) on 2022-06-01, disclosed to the SEC on 2022-06-03.
Open-market purchase of $9k INVO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.